This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked PDZK1 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-PDZK1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~57.1 kDa | |
| Gel | 12–15% (standard starting point) | |
| Positive control | Duodenum (IHC candidate; verify WB) +4 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Phosphorylated | |
| Caveat | Phosphorylation-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 2 isoform(s) |
The M03176-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | T47-D cell lysate (catalog M03176-1) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | M03176-1; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
PDZK1 is predicted at 57.1 kDa; isoforms and phosphorylation could affect migration, but no empirical band or feature-dependent shift is established.
| Band near 57.1 kDa | Compatible with the predicted PDZK1 mass; confirm identity with controls |
| Additional band at a different size | Could reflect isoform 1 or 2; their migration is not established |
| Slightly shifted band or doublet | Could reflect phosphorylation; a visible shift is not established |
| Weak band in a soluble fraction | PDZK1 associates with peripheral membranes |
| Predicted PDZK1 mass | Places the reference band near 57.1 kDa |
| Isoform 1 | May migrate differently from isoform 2; its mass is not supplied |
| Isoform 2 | May migrate differently from isoform 1; its mass is not supplied |
| Documented phosphoserine and phosphothreonine sites | Could affect migration, but no visible size shift is established |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Peripheral membrane association or insufficient PDZK1 in the sample | Check a membrane-enriched fraction and verify sample expression |
| Band higher than expected | Phosphorylation is documented, but the band identity and cause of the shift are unknown | Compare phosphatase-treated material and confirm PDZK1 with depletion controls |
| Band lower than expected | An isoform or protein breakdown may account for a smaller band | Compare isoform expression and confirm the band with PDZK1 depletion controls |
| Multiple bands | Two isoforms or phosphorylated forms are possible; distinct migration is unverified | Use PDZK1 depletion and phosphatase treatment to identify the bands |
| Weak or no signal | PDZK1 may be poorly recovered from membrane-associated material | Check extraction and sample loading with a suitable control |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Duodenum | endocrine cells | High | Protein (IHC) | HPA → |
| Kidney | bowman's capsule | High | Protein (IHC) | HPA → |
| Small intestine | endocrine cells | High | Protein (IHC) | HPA → |
| Colon | mucosal lymphoid cells | Medium | Protein (IHC) | HPA → |
| Gallbladder | glandular cells | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Not detected | Protein (IHC) | HPA → |
| Appendix | endocrine cells | Not detected | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Breast | adipocytes | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for PDZK1, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Both listed anti-PDZK1 antibodies have Western blot images. M03176-1 was shown with T47-D lysate; A03176-1 was shown with human cell and rat and mouse tissue lysates. A03176-1 detected a band near 70 kDa, above the stated 57 kDa expectation.
Which to pick: For human T47-D lysate, consider M03176-1. For the listed human cell lines or rat and mouse tissues, A03176-1 has the more directly relevant image. Check the observed 70 kDa band against your expected result.